Blood biomarker associated with prevalence, severity of Alzheimer's, but not risk of development

Higher levels in blood of the protein clusterin, also known as apolipoprotein J, are significantly associated with the prevalence and severity of Alzheimer's disease, but not with the risk of onset of new disease, according to a study in the April 6 issue of JAMA...

Read the whole article on

More from